Davidson Capital Management Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Davidson Capital Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$595.12 - $698.43 $2,380 - $2,793	-4 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$472.8 - $558.54 $1.06 Million - $1.26 Million	-2,250 Reduced 99.82%	4 $2,000
Q1 2021 May 10, 2021	BUY	$446.73 - $548.2 $392,675 - $481,867	879 Added 63.93%	2,254 $1.07 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $24,871 - $31,614	52 Added 3.93%	1,375 $664,000
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $22,334 - $26,986	41 Added 3.2%	1,323 $741,000

Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $302,898 - $395,366	-614 Reduced 32.38%	1,282 $800,000
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $637,397 - $937,439	1,896 New	1,896 $926,000

1,430

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $115B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Davidson Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Davidson Capital Management Inc. with notifications on news.